Compare Lupin Ltd with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs DR. REDDYS LAB - Comparison Results

LUPIN     Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN DR. REDDYS LAB LUPIN/
DR. REDDYS LAB
 
P/E (TTM) x 105.7 17.0 621.6% View Chart
P/BV x 2.4 3.3 73.7% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 LUPIN   DR. REDDYS LAB
EQUITY SHARE DATA
    LUPIN
Mar-19
DR. REDDYS LAB
Mar-19
LUPIN/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs9862,875 34.3%   
Low Rs7201,888 38.2%   
Sales per share (Unadj.) Rs369.5930.2 39.7%  
Earnings per share (Unadj.) Rs13.4117.4 11.4%  
Cash flow per share (Unadj.) Rs37.4185.8 20.1%  
Dividends per share (Unadj.) Rs020.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs303.7844.4 36.0%  
Shares outstanding (eoy) m452.49166.07 272.5%   
Bonus/Rights/Conversions ESOPESOP-  
Price / Sales ratio x2.32.6 90.2%   
Avg P/E ratio x63.620.3 313.8%  
P/CF ratio (eoy) x22.812.8 178.0%  
Price / Book Value ratio x2.82.8 99.6%  
Dividend payout %017.0 0.0%   
Avg Mkt Cap Rs m386,064395,496 97.6%   
No. of employees `00017.722.0 80.5%   
Total wages/salary Rs m31,51333,562 93.9%   
Avg. sales/employee Rs Th9,453.87,032.8 134.4%   
Avg. wages/employee Rs Th1,782.01,527.9 116.6%   
Avg. net profit/employee Rs Th343.0887.7 38.6%   
INCOME DATA
Net Sales Rs m167,182154,482 108.2%  
Other income Rs m3,6403,375 107.9%   
Total revenues Rs m170,822157,857 108.2%   
Gross profit Rs m28,82231,782 90.7%  
Depreciation Rs m10,85011,348 95.6%   
Interest Rs m3,078889 346.3%   
Profit before tax Rs m18,53422,920 80.9%   
Minority Interest Rs m-890-   
Prior Period Items Rs m38438 8.6%   
Extraordinary Inc (Exp) Rs m-3,4000-   
Tax Rs m9,0173,858 233.7%   
Profit after tax Rs m6,06619,500 31.1%  
Gross profit margin %17.220.6 83.8%  
Effective tax rate %48.716.8 289.0%   
Net profit margin %3.612.6 28.7%  
BALANCE SHEET DATA
Current assets Rs m138,536111,101 124.7%   
Current liabilities Rs m61,29958,973 103.9%   
Net working cap to sales %46.233.7 136.9%  
Current ratio x2.31.9 120.0%  
Inventory Days Days8479 105.6%  
Debtors Days Days11294 119.4%  
Net fixed assets Rs m127,516101,245 125.9%   
Share capital Rs m905830 109.0%   
"Free" reserves Rs m136,517139,406 97.9%   
Net worth Rs m137,422140,236 98.0%   
Long term debt Rs m66,41722,000 301.9%   
Total assets Rs m279,494224,656 124.4%  
Interest coverage x7.026.8 26.2%   
Debt to equity ratio x0.50.2 308.1%  
Sales to assets ratio x0.60.7 87.0%   
Return on assets %3.39.1 36.0%  
Return on equity %4.413.9 31.7%  
Return on capital %8.914.9 59.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m59,41488,673 67.0%   
Fx outflow Rs m22,28219,104 116.6%   
Net fx Rs m37,13269,569 53.4%   
CASH FLOW
From Operations Rs m16,66028,704 58.0%  
From Investments Rs m-32,825-7,727 424.8%  
From Financial Activity Rs m7,441-21,326 -34.9%  
Net Cashflow Rs m-8,724-314 2,778.2%  

Share Holding

Indian Promoters % 46.6 25.5 182.7%  
Foreign collaborators % 0.2 0.0 -  
Indian inst/Mut Fund % 11.3 5.4 209.3%  
FIIs % 31.9 35.3 90.4%  
ADR/GDR % 0.0 18.5 -  
Free float % 10.1 15.3 66.0%  
Shareholders   98,259 75,885 129.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   CIPLA  PIRAMAL ENTERPRISES  ALKEM LABORATORIES  SUN PHARMA  PFIZER  

Compare LUPIN With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 229 Points Lower; Banking and Metal Stocks Witness Selling(Closing)

Indian share markets fell sharply during closing hours today amid weak global cues and disappointing domestic factory output data.

Related Views on News

LUPIN Announces Quarterly Results (2QFY20); Net Profit Down 146.4% (Quarterly Result Update)

Nov 7, 2019 | Updated on Nov 7, 2019

For the quarter ended September 2019, LUPIN has posted a net profit of Rs 1 bn (down 146.4% YoY). Sales on the other hand came in at Rs 44 bn (up 10.3% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN Announces Quarterly Results (1QFY20); Net Profit Up 49.3% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, LUPIN has posted a net profit of Rs 3 bn (up 49.3% YoY). Sales on the other hand came in at Rs 44 bn (up 14.6% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of LUPIN for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

LUPIN Announces Quarterly Results (4QFY19); Net Profit Down 1.5% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, LUPIN has posted a net profit of Rs 3 bn (down 1.5% YoY). Sales on the other hand came in at Rs 44 bn (up 77.8% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN LTD Announces Quarterly Results (3QFY19); Net Profit Down 149.7% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, LUPIN LTD has posted a net profit of Rs 2 bn (down 149.7% YoY). Sales on the other hand came in at Rs 45 bn (up 78.0% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

More Views on News

Most Popular

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN SHARE PRICE


Nov 13, 2019 03:37 PM

TRACK LUPIN

LUPIN - SANOFI INDIA COMPARISON

COMPARE LUPIN WITH

MARKET STATS